Trial Profile
Phase II treatment of adults with primary malignant glioma with irinotecan plus temozolomide.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 May 2021
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Temozolomide (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 19 Aug 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
- 19 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jan 2009 Additional trial investigator identified as reported by ClinicalTrials.gov, last updated 22 Jan 2009